Latest stories on MLTX
H.C. Wainwright reiterates Moonlake stock buy rating on funding
Investing.com Analyst Ratings61 · neutralanalyst
SLS Vs MLTX: Retail Traders Race To Pick Merck’s Next Biotech Buyout As Keytruda’s $31.7B Patent Cliff Nears
Stocktwits News56 · neutralgeneral
MoonLake Immunotherapeutics' CFO Sells 39K Shares
The Motley Fool42 · neutralgeneral
MoonLake: 'Buy' Sonelokimab BLA Submission HS September And Label Expansion
Seeking Alpha67 · bullishproduct/pr
MoonLake Immunotherapeutics (MLTX) files 8-K
SEC 8-K50 · neutralgeneral
Why MoonLake Immunotherapeutics Stock Wilted on Wednesday
The Motley Fool28 · bearishgeneral
MLTX Stock Extends Pullback After Biggest Rally In Over 6 Months Following Skin Disease Trial Data — A Look At The Latest Development
Stocktwits News24 · bearishgeneral
MoonLake Immunotherapeutics prices $200M public offering of Class A shares
Seeking Alpha24 · bearishgeneral
MoonLake Immunotherapeutics Announces Pricing of Upsized $200 Million Public Offering | MLTX Stock News
StockTitan24 · bearishgeneral
MoonLake Immunotherapeutics: Label Upside Drives The Next Leg Higher
Seeking Alpha73 · bullishproduct/pr
MLTX Stock Clocks Best Day In Over 6 Months — What’s Driving The Investor Optimism?
Stocktwits News67 · bullishproduct/pr
Stocks to watch on Monday after hours: MLTX, BBY, and DPZ
Seeking Alpha47 · neutralgeneral
MoonLake Immunotherapeutics (MLTX) Analyst/Investor Day - Slideshow
Seeking Alpha50 · neutralgeneral
MoonLake Immunotherapeutics Announces Proposed Public Offering | MLTX Stock News
StockTitan24 · bearishgeneral
MoonLake Immunotherapeutics (MLTX) Analyst/Investor Day Transcript
Seeking Alpha55 · neutralgeneral
MoonLake Highlights Strong Phase 3 Sonelokimab HS Results
TipRanks67 · bullishproduct/pr
MoonLake's Sonelokimab Delivers Leading Efficacy and Quality-of-Life Gains in Phase 3 HS Trial as FDA Filing Nears
MarketChameleon73 · bullishproduct/pr
MoonLake Immunotherapeutics (MLTX) files 8-K
SEC 8-K50 · neutralgeneral
Why Is MLTX Stock Rallying Nearly 20% Overnight?
Stocktwits News67 · bullishproduct/pr
MoonLake eyes FDA filing this fall on one-year results for skin treatment
Seeking Alpha73 · bullishproduct/pr
MLTX Stock Moves Higher As Traders Position For Late-Stage Trial Catalysts
Stocktwits News63 · neutralproduct/pr
MoonLake Immunotherapeutics (MLTX) files 8-K
SEC 8-K50 · neutralgeneral
Why Did MLTX Stock Rise After-Hours Today?
Stocktwits News56 · neutralproduct/pr